Loading interface...

Vomistop 30 MG Tablet

Manufactured byCipla Ltd.
ContainsDomperidone
Description

Vomistop 30 MG Tablet is an effective anti-emetic used to relieve nausea and vomiting caused by a slow-moving stomach resulting in delayed emptying. It increases the intestinal movements and facilitates the emptying of the bowel.

Side effects

Major & minor side effects for Vomistop 30 MG Tablet

  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Difficulty in breathing
  • Skin rash
  • Convulsions
  • Irregular heartbeat
  • Disrupted menstrual cycle
  • Breast pain and tenderness
  • Dry mouth
  • Chest pain
  • Dizziness and fainting
  • Extreme tiredness

Uses of Vomistop 30 MG Tablet

What is it prescribed for?

  • Nausea and vomiting
  • Gastric motility disorders
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effects of this medicine can be observed within 30 to 60 minutes of administration.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 6 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless the potential benefits outweigh the risks involved. The effect of this medicine on the fetus is not clearly established and hence you are advised to consult a doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use by breastfeeding mothers as there is a risk of side effects on the infant. You are advised to consult your doctors and consider the potential benefit and risks before consuming this medication.

Allergy

This medicine is not recommended for use in patients with a known allergy to domperidone or any other inactive ingredients present in the formulation.

Tumor of Pituitary gland

This medicine is not recommended for use in patients with a tumor of the pituitary gland due to the increased risk of worsening the patient's condition.

Heart diseases

This medicine is not recommended for use in patients with heart disease like congestive heart failure due to the increased risk of worsening of the patient's condition.

Moderate to severe liver impairment

This medicine is not recommended for use in patients with moderate to severe liver impairment due to the increased risk of worsening the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless the potential benefits outweigh the risks involved. The effect of this medicine on the fetus is not clearly established and hence you are advised to consult a doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use by breastfeeding mothers as there is a risk of side effects on the infant. You are advised to consult your doctors and consider the potential benefit and risks before consuming this medication.
General warnings

Other medicines

This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Use in children

This medicine is not recommended for use in patients less than 12 years of age and weighing less than 35 kg since the safety and efficacy of use are not clinically established.

Use in elderly population

This medicine should be used with extreme caution in elderly patients above 65 years of age due to the risk of adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Cardiovascular diseases

This medicine should be used with caution in patients with a known history of cardiovascular disorders due to the increased risk of serious adverse effects. Close monitoring of heart function and vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Electrolyte imbalance

This medicine should be used with extreme caution in patients with acute or long-term electrolyte imbalance in the body due to the increased risk of worsening of the patient's condition. Regular monitoring of electrolyte levels should be done while receiving this medicine. An alternative treatment option should be considered in some cases based on the clinical condition.

Prolactin imbalance

This medicine should be used with caution since it may increase the risk of imbalance in the levels of prolactin, resulting in disturbances in the menstrual cycle in women. Prolonged use of this medicine can also result in breast like growth in men.

Dosage and duration of uptake

This medicine should be used for the shortest duration possible. The dose should be kept as low as possible. Self-administration is not advised owing to these reasons.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Cisapride

Erythromycin

Ketoconazole

Tramadol

Bromocriptine

Disease interactions

Kidney Disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Liver impairment

This medicine should be used with extreme caution in patients with mild liver impairment due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition. It is not recommended for use in patients with moderate to severe liver impairment.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine as directed by the doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting the doctor.
Miscelleneous

To be taken before food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by blocking certain chemicals in the brain and the intestine. This causes faster gastric emptying and helps in the prevention of nausea and vomiting.
Legal Status

Approved

Banned

Approved

Approved

Classification

Category

Antiemetics

Schedule

Schedule H

Domperidone | C22H24ClN5O2 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 8 March 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/3151

Domperidone 10mg Tablets - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2020 [cited 25 February 2020]. Available from:

https://www.medicines.org.uk/emc/medicine/23098

[Internet]. Medsafe.govt.nz. 2020 [cited 25 February 2020]. Available from:

https://www.medsafe.govt.nz/Consumers/CMI/d/domperidone.pdf

[Internet]. Lagaay.com. 2020 [cited 25 February 2020]. Available from:

https://www.lagaay.com/Catalogus/Product%20information/026390/Domperidon%2010mg%20Leaflet.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 20 Apr 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.